Search Results

There are 112613 results for: content related to: Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

  1. Die Veränderung der Brutvogelfauna in zwei süddeutschen Dorfgemeindebereichen in den letzten fünf bzw. drei Jahrzehnten oder: verlorene Paradiese?

    Journal für Ornithologie

    Volume 144, Issue 4, October 2003, Pages: 385–410, Peter Berthold

    Version of Record online : 8 MAR 2004, DOI: 10.1111/j.1439-0361.2003.03046.x

  2. Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time

    Reviews in Medical Virology

    Volume 26, Issue 6, November 2016, Pages: 408–434, Lize Cuypers, Francesca Ceccherini-Silberstein, Kristel Van Laethem, Guangdi Li, Anne-Mieke Vandamme and Jürgen Kurt Rockstroh

    Version of Record online : 12 JUL 2016, DOI: 10.1002/rmv.1895

  3. You have full text access to this OnlineOpen article
    Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients

    Journal of Viral Hepatitis

    Volume 22, Issue 11, November 2015, Pages: 882–889, S. Cure, I. Guerra and G. Dusheiko

    Version of Record online : 7 APR 2015, DOI: 10.1111/jvh.12409

  4. You have free access to this content
    Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 12, June 2016, Pages: 1276–1292, A. Majumdar, M. T. Kitson and S. K. Roberts

    Version of Record online : 18 APR 2016, DOI: 10.1111/apt.13633

  5. You have free access to this content
    Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

    Liver Transplantation

    Volume 14, Issue 12, December 2008, Pages: 1766–1777, Bruno Roche, Mylene Sebagh, Maria Laura Canfora, Teresa Antonini, Anne-Marie Roque-Afonso, Valerie Delvart, Faouzi Saliba, Jean-Charles Duclos-Vallee, Denis Castaing and Didier Samuel

    Version of Record online : 24 NOV 2008, DOI: 10.1002/lt.21635

  6. You have free access to this content
    Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 969–983, A. G. Singal, A. K. Waljee, M. Shiffman, B. R. Bacon and P. S. Schoenfeld

    Version of Record online : 15 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04427.x

  7. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  8. You have free access to this content
    Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting

    Transplant International

    Volume 28, Issue 9, September 2015, Pages: 1011–1024, Sandra Beinhardt, Markus Peck-Radosavljevic, Harald Hofer and Peter Ferenci

    Version of Record online : 23 APR 2015, DOI: 10.1111/tri.12577

  9. You have free access to this content
    Review article: predicting response in hepatitis C virus therapy

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 8, April 2006, Pages: 1043–1054, U. MIHM, E. HERRMANN, C. SARRAZIN and S. ZEUZEM

    Version of Record online : 30 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02863.x

  10. You have free access to this content
    Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 30–36, Ehsaan Akhtar, Vignan Manne and Sammy Saab

    Version of Record online : 22 MAY 2014, DOI: 10.1111/liv.12576

  11. You have free access to this content
    Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 6, March 2015, Pages: 544–563, Z. M. Younossi, H. Park, S. Saab, A. Ahmed, D. Dieterich and S. C. Gordon

    Version of Record online : 26 JAN 2015, DOI: 10.1111/apt.13081

  12. You have full text access to this OnlineOpen article
    Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

    Liver International

    Volume 37, Issue 1, January 2017, Pages: 5–18, Jordan J. Feld, Ira M. Jacobson, Mark S. Sulkowski, Fred Poordad, Fernando Tatsch and Jean-Michel Pawlotsky

    Version of Record online : 29 SEP 2016, DOI: 10.1111/liv.13212

  13. Treat chronic hepatitis C virus infection in decompensated cirrhosis – pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy

    Journal of Viral Hepatitis

    Volume 23, Issue 6, June 2016, Pages: 408–418, C. Bunchorntavakul and K. Rajender Reddy

    Version of Record online : 28 MAR 2016, DOI: 10.1111/jvh.12534

  14. Ten-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-α and ribavirin therapy

    Journal of Viral Hepatitis

    Volume 23, Issue 12, December 2016, Pages: 971–976, X. Wang, F. Gao, G. Yuan, K. Shi, Y. Huang, Y. Chen, R. Qiu, L. Sun, J. Liu, C. Hu and Y. Zhou

    Version of Record online : 24 JUL 2016, DOI: 10.1111/jvh.12574

  15. You have free access to this content
    Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 12, December 2014, Pages: 1653–1666, Bryant B. Summers, Joshua W. F. Beavers and Olga M. Klibanov

    Version of Record online : 31 AUG 2014, DOI: 10.1111/jphp.12294

  16. Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

    Hepatology

    Volume 64, Issue 4, October 2016, Pages: 1331–1342, Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi and Mario Strazzabosco

    Version of Record online : 4 APR 2016, DOI: 10.1002/hep.28527

  17. Hepatitis B and C in liver transplantation: new strategies to combat the enemies

    Reviews in Medical Virology

    Volume 23, Issue 3, May 2013, Pages: 172–193, Susanne Beckebaum, Iyad Kabar and Vito R. Cicinnati

    Version of Record online : 13 DEC 2012, DOI: 10.1002/rmv.1734

  18. You have free access to this content
    Liver transplantation for hepatitis C

    Journal of Hepato-Biliary-Pancreatic Surgery

    Volume 13, Issue 5, September 2006, Pages: 382–392, Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita and Morito Monden

    Version of Record online : 1 SEP 2006, DOI: 10.1007/s00534-005-1078-9

  19. You have full text access to this OnlineOpen article
    The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

    Journal of Viral Hepatitis

    Volume 20, Issue 11, November 2013, Pages: 745–760, N. H. Afdhal, S. Zeuzem, R. T. Schooley, D. L. Thomas, J. W. Ward, A. H. Litwin, H. Razavi, L. Castera, T. Poynard, A. Muir, S. H. Mehta, L. Dee, C. Graham, D. R. Church, A. H. Talal, M. S. Sulkowski, I. M. Jacobson and for the New Paradigm of HCV Therapy Meeting Participants

    Version of Record online : 7 OCT 2013, DOI: 10.1111/jvh.12173

  20. You have free access to this content
    Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 10, May 2007, Pages: 1153–1162, M. SIMIN, J. BROK, D. STIMAC, C. GLUUD and L. L. GLUUD

    Version of Record online : 19 FEB 2007, DOI: 10.1111/j.1365-2036.2007.03294.x